Inovio Pharmaceuticals, Inc. Recorded Big Gain

Inovio Pharmaceuticals, Inc. (INO:NASDAQ) soared at $7.45, a gain of 69.7%. On Mon 02 Mar 20, INO:NASDAQ touched a New 2-Week High of $4.39. The stock appeared on our News Catalysts scanner on Tue 03 Mar 20 at 04:15 AM in the 'BIOTECH' category. From Mon 10 Feb 20, the stock recorded 57.14% Up Days and 26.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Inovio Pharmaceuticals, Inc. (INO:NASDAQ)
Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.
Top 10 Gainers:
- Inovio Pharmaceuticals, Inc. (INO:NASDAQ), 69.7%
- Stealth BioTherapeutics Corp (MITO:NASDAQ), 61.58%
- Superconductor Technologies Inc. (SCON:NASDAQ), 59.19%
- Omeros Corporation (OMER:NASDAQ), 55.36%
- NCS Multistage Holdings, Inc. (NCSM:NASDAQ), 52.43%
- Glowpoint, Inc. (GLOW:NYSEMKT), 49.57%
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 34.15%
- Pacific Ethanol, Inc. (PEIX:NASDAQ), 31.65%
- NuCana plc (NCNA:NASDAQ), 31.05%
- Vislink Technologies, Inc. (VISL:NASDAQ), 30.81%